Prediabetes: Making a Diagnosis and Selecting a Treatment Approach

Поділитися
Вставка
  • Опубліковано 13 лип 2024
  • The webcast uses a case-based lesson to review the efficacy, safety, and pharmacologic profile of incretin therapies in the prevention and treatment of type 2 diabetes. Visit www.ccfcme.org/incretinvgrvideos to claim CME credit or learn more about the Incretin-Related Therapies in Diabetes series.
    The glycemic control webcast features expert faculty member, George Grunberger, MD, of the Grunberger Diabetes Institute, with commentary by Activity Director, Charles Faiman, MD.
    The video was produced by the Cleveland Clinic Foundation Center for Continuing Education and the Endocrine, Diabetes & Metabolism Institute.
    Interested in related CME education? Visit www.clevelandclinicmeded.com/m...

КОМЕНТАРІ • 2

  • @shahzadi72
    @shahzadi72 9 років тому

    Dear sir,if FDA not allowed any pharmacological agent for pre DM ,why to talk about?